With more than 30 years of experience, Sciensus is a trusted life sciences partner that helps biopharma, CROs and CCOs navigate the complexity of the European healthcare ecosystem to maximise product value and impact for patients.
We look forward to connecting at BIO to explore how we can help get your therapies to European patients faster – helping patients start therapy sooner, stay on it longer, and achieve better outcomes.
Meet the Sciensus team at BIO
Chief Executive Officer
Christian Tucat
Head of Medical Affairs and Growth Strategy
Alastair MacDonald
Vice President, Rare Disease Strategy
Ray Huml
Vice President, Business Development
Andrew Cummins
SVP, Business Development North America
Mandi Walters
SVP, Business Development North America & APAC
Jeremy Mangelson
Ensure your treatments reach patients where they are
Let’s connect at BIO. Whether you’re launching a new therapy, scaling across Europe, or designing a hybrid patient journey – we can help get treatments to patients who need them.
Accelerating development from trial to treatment
The challenge with drug development and commercialisation isn’t just innovation – it’s also implementation. From clinical trials to product launches, getting the right medicine to the right patient, at the right time, is more important than ever.
Sciensus delivers a faster, smarter route from trial to treatment – helping patients start therapy sooner, stay on it longer, and achieve better outcomes.
Expertise that makes the difference
Leveraging over 30 years of clinical experience, deep therapeutic expertise, and personalised digital innovation, we help biopharma, CROs and CCOs bring treatments to patients across Europe faster.
0 +
patient interactions across Europe
0
clinical deliveries annually
0 +
cancers treated via systemic anti-cancer therapies
0 +
regimens across 125 medicines
What we deliver for life science partners
Established supply chain & logistics capabilities
Secure, specialist storage and distribution of medicines across Europe – to hospitals, pharmacies, and directly to patients.
Early access and trial support
Accelerate access to therapy through Early Access Programmes, Managed Access Programmes, decentralised trial activity and recruitment support across EU markets.
Real-world evidence generation
Real-world insights from millions of patient touchpoints, supporting Integrated Evidence Planning, Healthcare Technology Assessment (HTA) submissions, and Patient Support Programme (PSP) optimisation.
Digital PSPs
Tech-enabled, nurse-supported programmes tailored for any disease state – from patient onboarding to long-term engagement. Through this we help patients start therapy sooner, stay on it longer, and achieve better outcomes – thanks to a combination of digital tools, in-home care, and real-world insights.
As a strategic partner, they have exceeded our expectations by finding global patients, who need our drugs, and enabling them to receive their life-extending medications.
Chief Commercial Officer at leading US Biotech company
Get in touch
Thank you for your interest in Sciensus. Whether you’re seeking information, partnership opportunities, or want to refer a patient, our dedicated team is here to assist you. Please fill out the form on the right, and one of our multi-lingual representatives will get in touch with you promptly.